What is the potential for using digital health tools to enhance vaccine uptake and adherence?

Jan 5, 2015 ... Valneva intends to finance the Acquisition with a combination of debt and equity. The latter will be raised through the launch of a public ... [Chol-Ecol-O] DUKORAL (VAL). Pan-Canadian SNOMED CT terminology. Concept ... information field is blank as it may not be applicable in the given context. It has been reported that vaccination can reduce the risk of contracting pertussis by 80% to 85%. - More information. ・World Health Organization (WHO): ... Company: Valneva Sweden AB. Status: New. Active Ingredient(s):. Oral cholera vaccine. *Additional information is available within the SPC or upon request to ... Data Sheet · Consumer Medicine Information. DUKORAL® is a registered trademark of Valneva Sweden AB. FERINJECT® | (ferric carboxymaltose) 50 mg/mL solution for ... Feb 6, 2025 ... Information about the vaccine manufacturer can be found in vaccine-specific chapters in Part 4. For more information about immunoglobulins, ... Below is a text only representation of the Patient Information Leaflet (ePIL). ... Do not use Dukoral. if you are allergic to any ingredient of the vaccine ... Dec 5, 2024 ... Researchers estimate that there are 1.3 to 4.0 million cases and 21 000 to 143 000 deaths from cholera worldwide each year (1). Most people with ... Dukoral can be given to all individuals over the age of 2 years. There must be a minimum of 7 days, and no more than 6 weeks, delay between each dose. Children ... What are the symptoms of cholera and when do they appear? People infected ... Freedom of Information Law (FOIL) · Forms. Current Issues/Info. Abortion in ...